— Know what they know.
Not Investment Advice

THRX NASDAQ

Theseus Pharmaceuticals, Inc.
1W: +0.0% 1M: +1.5% 3M: +20.5% 1Y: -59.9%
$4.07
Last traded 2024-02-23 — delisted
NASDAQ · Healthcare · Biotechnology · $181.5M mcap · 14M float · 3.06% daily turnover

Balance Sheet Trends

Total Assets
$222M -11.4% ▼
3Y CAGR: +438.2%
Total Liabilities
$15M +230.0% ▲
3Y CAGR: +11.0%
Shareholders Equity
$208M -15.8% ▼
Cash & Investments
$198M -19.1% ▼
3Y CAGR: +431.7%
Total Debt
$4M +0.0% ▲
Net Debt
-$91M +63.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022
— Assets —
Cash$1M$8M$245M$95M
Short-Term Investments$0$0$0$103M
Cash & ST Investments$1M$8M$245M$198M
Net Receivables$0$0$0$0
Inventory$0$0$0$0
Other Current Assets$64K$113K$3M$4M
Total Current Assets$1M$9M$248M$198M
Property, Plant & Equip.$3K$1K$11K$5M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$379K$14M
Other Non-Current Assets$43K$43K$3M$6M
Total Non-Current Assets$46K$44K$3M$24M
Total Assets$1M$9M$251M$222M
— Liabilities —
Accounts Payable$285K$1M$1M$5M
Short-Term Debt$0$0$0$743K
Deferred Revenue$0$0$0$0
Other Current Liabilities$330K$463K$3M$5M
Total Current Liabilities$615K$2M$4M$11M
Long-Term Debt$0$0$0$3M
Other Non-Current Liab.$10M$41M$815K$466K
Total Non-Current Liabilities$10M$41M$815K$4M
Total Liabilities$11M$43M$4M$15M
— Equity —
Common Stock$0$0$4K$4K
Retained Earnings-$10M-$34M-$62M-$112M
Accumulated OCI$813K$0-$251M-$386K
Total Stockholders Equity-$9M-$34M$246M$208M
Total Liabilities & Equity$1M$9M$251M$222M
— Key Metrics —
Total Debt$0$0$0$4M
Net Debt-$1M-$8M-$245M-$91M
Total Investments$0$0$379K$117M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms